IMMUNOCORE LIMITED

PaymentCheck Score 2021
41Poor
1.4vs last year
#5015 in UK
#62 in Life Sciences And Medical Technology
#861 in South East

Company Information

Company Number
06456207
Registered Address
92 Park Drive, Milton Park, Abingdon, Oxfordshire, United Kingdom, OX14 4RY
Status
Active
Employee Count
293
Turnover
£179,049,000
EBITDA
£23,343,000

Additional Details

Company Type
Private limited Company
Incorporated On
18 December 2007
Nature of Business
72190 - Other research and experimental development on natural sciences and engineering
Industries
Life Sciences And Medical Technology
Region
South East

Time to Pay

Average Time to Pay
41 days
Shortest Period:0 days
Longest Period:30 days
Max Contractual:30 days

Payment Timeline

Within 30 Days
19%
31-60 Days
74%
After 60 Days
7%
Not Paid Within Terms81%

Payment Features

Participates in Codes✗ No
E-Invoicing✗ No
Supply Chain Finance✗ No

Payment Score History

Excellent (80+) Good (60-79) Fair (40-59) Poor (20-39) Very Poor (<20)

Performance Reports History

Reporting Period Filed: 2021-08-25
Reporting PeriodFiling DateAverage Time to Pay (days)Paid within 30 daysPaid 31-60 daysPaid after 60 daysNot Paid within Terms
01 Feb 2021 - 31 Jul 202125 Aug 20214119%74%7%81%
01 Aug 2020 - 31 Jan 202130 Mar 20214021%73%6%74%
01 Feb 2020 - 31 Jul 202024 Aug 20204113%79%8%86%
01 Aug 2019 - 31 Jan 202003 Mar 20204312%83%6%88%
01 Aug 2018 - 31 Jan 201911 Mar 20192383%16%2%18%

Payment Time Trends

Payment Distribution Trends

Invoice Payment Practices

This information is as reported by the business, and responses are in their own words.

Payment Terms

Standard payment terms

30 days from invoice date

Were there any changes to the standard payment terms in the reporting period?

No information available

Any other information about payment terms

No additional information

Maximum contractual payment period agreed

30

Dispute Resolution Process

Any disputes on individual invoices are raised in the first instance to the finance email box or by phone to the finance team. They will work with the supplier to resolve the issue. WE aim to resolve issues raised by suppliers within 5 working days, but we typically respond the next working day. Any contractual disputes are managed though our commercial contract management process.

Other Payment Information

Has this business signed up to a code of conduct or standards on payment practices?

For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.

Does this business offer e-invoicing in relation to qualifying contracts?

This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.

Does this business offer supply chain finance?

This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.

Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?

During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?

No information available

Company Summary

IMMUNOCORE LIMITED is a British biotechnology company that specializes in the development of innovative immunotherapies for the treatment of cancer, infectious diseases, and autoimmune disorders. The company was founded in 2008 and is headquartered in Abingdon, Oxfordshire.

The main focus of IMMUNOCORE LIMITED is to develop and commercialize its proprietary platform technology, ImmTAC (Immune Mobilizing Monoclonal T-Cell Receptor Against Cancer). This technology is designed to activate the body's immune system to target and destroy cancer cells.

In addition to its innovative products, IMMUNOCORE LIMITED is committed to sustainability and minimizing its environmental impact. The company has implemented various initiatives to reduce waste, conserve energy, and promote sustainable practices throughout its operations.

The key people at IMMUNOCORE LIMITED include CEO Dr. Bahija Jallal, who has over 25 years of experience in the biopharmaceutical industry, and Chairman Dr. Jonathan Knowles, a renowned scientist and entrepreneur.

For more information about IMMUNOCORE LIMITED and its products and services, individuals can visit their website at www.immunocore.com. The company's registered office address is located at 1030 Eskdale Road, Abingdon, Oxfordshire, OX14 4SA, United Kingdom.

Financial Metrics

Cash
£293,548,000
Net Worth
-£2,067,000
Total Current Assets
£413,402,000
Total Current Liabilities
£391,405,000

Company Location